web analytics

Cyxone's CEO Kjell G. Stenberg increases holding in the company for private account

Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that the company’s CEO Kjell G. Stenberg has for private account increased his stake in the company by acquiring an additional 9,154 shares at a share price of 5.89 SEK.
Kjell G. Stenberg, CEO of Cyxone, commented: “I recently returned from a successful partnering conference, Nordic Life Science Days, held this week in Malmö. It was great fun to meet several new contacts and update existing contacts with the latest progress we have made with the portfolio. Our candidates have great potential, which is why I choose to

Source: Cyxone's CEO Kjell G. Stenberg increases holding in the company for private account

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.